Compounds > whi p154
Page last updated: 2024-10-29

whi p154 and Leucocythaemia

whi p154 has been researched along with Leucocythaemia in 2 studies

WHI P154: an anti-leukemic agent; structure in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sudbeck, EA2
Liu, XP2
Narla, RK1
Mahajan, S1
Ghosh, S2
Mao, C1
Uckun, FM2
Zheng, Y1
Myers, DE1

Reviews

1 review available for whi p154 and Leucocythaemia

ArticleYear
Tyrosine kinase inhibitors against EGF receptor-positive malignancies.
    Methods in molecular biology (Clifton, N.J.), 2001, Volume: 166

    Topics: Adenocarcinoma; Amides; Aniline Compounds; Animals; Antineoplastic Agents; Breast Neoplasms; Drug De

2001

Other Studies

1 other study available for whi p154 and Leucocythaemia

ArticleYear
Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Computer Simulation; Drug Design; Drug Evaluation,

1999